Japan’s All-Genome Project Hopes To Push Pharma R&D
Cancer, Rare Disease Focus But Calls For More Patient Focus
Japan is aiming for the betterment of pharma R&D and medical services for rare disease patients by building a database connecting genome analysis data and clinical records. While several clinical studies are planned for the next couple of years, there are also concerns around the actual trickle-down of benefits to patients and data privacy.
